We may earn a commission from links on this page

Ozempic competitor in the works at Amgen reaches late-stage clinical trials

Ozempic competitor in the works at Amgen reaches late-stage clinical trials

The pharma company announced today that it has begun two late-stage clinical trials for its experimental weight-loss drug, MariTide

PublishedYesterday

We may earn a commission from links on this page.

Video Program Guide

Latest Videos Most Popular What's Next For...?Smart Investing

Latest Videos

Slide 1 of 16

Ozempic competitor in the works at Amgen reaches late-stage clinical trials

Ozempic competitor in the works at Amgen reaches late-stage clinical trials

Target's CEO warns that tariffs could drive up prices on popular items within a week. Here's what may cost more

Target's CEO warns that tariffs could drive up prices on popular items within a week. Here's what may cost more

Nvidia, Dell, and Super Micro stock tumble as new China probe sparks fears of tighter scrutiny

Nvidia, Dell, and Super Micro stock tumble as new China probe sparks fears of tighter scrutiny

Nvidia's record earnings reveal just 3 customers make up 30% of revenue

Nvidia's record earnings reveal just 3 customers make up 30% of revenue

Bitcoin price plunges below $85,000. Here's what might be causing it

Bitcoin price plunges below $85,000. Here's what might be causing it

Most Popular

Slide 1 of 16

Starbucks just cut its menu down to size. It’s not what you think

Starbucks just cut its menu down to size. It’s not what you think

Tariffs, interest rates, and market volatility: What they mean for your investments in 2025, according to a strategist

Tariffs, interest rates, and market volatility: What they mean for your investments in 2025, according to a strategist

AI trip planners will soon be better than human travel agents, Booking Holdings CEO Glenn Fogel said

AI trip planners will soon be better than human travel agents, Booking Holdings CEO Glenn Fogel said

Inside Barron Trump’s high-end real estate ambitions with GOP connections

Inside Barron Trump’s high-end real estate ambitions with GOP connections

Microsoft and Gretel team up to drive AI innovation

Microsoft and Gretel team up to drive AI innovation

What's Next For...?

Slide 1 of 13

HGTV's Property Brothers react to mortgage rates rising over 7%

HGTV's Property Brothers react to mortgage rates rising over 7%

Amazon's new pharmacy won't do much for its bottom line, analyst says

Amazon's new pharmacy won't do much for its bottom line, analyst says

Kara Swisher on why Google's AI will surpass OpenAI

Kara Swisher on why Google's AI will surpass OpenAI

Are we in an AI bubble? | What’s next for Nvidia?

Are we in an AI bubble? | What’s next for Nvidia?

Why Bitcoin won’t reach $1,000,000 | What’s next for Bitcoin?

Why Bitcoin won’t reach $1,000,000 | What’s next for Bitcoin?

Smart Investing

Slide 1 of 24

Extreme trade and immigration policies could slow growth and fuel stagflation, strategist warns

Extreme trade and immigration policies could slow growth and fuel stagflation, strategist warns

Fear is rising, but stock bets are bigger than ever. Here’s why

Fear is rising, but stock bets are bigger than ever. Here’s why

Ford's CEO warns of ‘chaos’ in the auto industry. Here’s what it means for investors

Ford's CEO warns of ‘chaos’ in the auto industry. Here’s what it means for investors

Trump's 25% tariffs could reshape markets — but don't panic yet, Deutsche Bank exec says

Trump's 25% tariffs could reshape markets — but don't panic yet, Deutsche Bank exec says

How investors can navigate the Sam Altman vs. Elon Musk feud, according to a Deutsche Bank exec

How investors can navigate the Sam Altman vs. Elon Musk feud, according to a Deutsche Bank exec

📬 Sign up for the Daily Brief

Our free, fast, and fun briefing on the global economy, delivered every weekday morning.

Advertisement

Advertisement